Literature DB >> 8340413

O6-methylguanine residues elicit DNA repair synthesis by human cell extracts.

P Karran1, P Macpherson, S Ceccotti, E Dogliotti, S Griffin, M Bignami.   

Abstract

We have investigated the processing of O6-methylguanine (O6-MeGua) in plasmid DNA by extracts of human cells defective in O6-MeGua-DNA methyltransferase. Cell extracts of HeLaMR cells performed viral T antigen-independent DNA synthesis on plasmids that had been treated with low concentrations of methylating agents. The in vitro DNA synthesis was non-semiconservative and depended on the presence of O6-MeGua in the substrate. The involvement of DNA polymerase delta or epsilon and proliferating cell nuclear antigen but not single-strand binding protein was indicated by partial fractionation, inhibitor, and antibody studies. Processing of O6-MeGua is not via the UV nucleotide excision repair pathway since additional component(s) are apparently required to perform repair synthesis on the methylated substrate. This is the first direct demonstration of DNA repair synthesis provoked by O6-MeGua in DNA. Since O6-MeGua is not excised from DNA by Mex- cells, it represents a novel type of processing of the methylated base that may be involved in its cytotoxicity.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8340413

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Multiple mutations and frameshifts are the hallmark of defective hPMS2 in pZ189-transfected human tumor cells.

Authors:  S Ceccotti; C Ciotta; G Fronza; E Dogliotti; M Bignami
Journal:  Nucleic Acids Res       Date:  2000-07-01       Impact factor: 16.971

2.  p50 (NF-κB1) is an effector protein in the cytotoxic response to DNA methylation damage.

Authors:  Adam M Schmitt; Clayton D Crawley; Shijune Kang; David R Raleigh; Xiaohong Yu; Joshua S Wahlstrom; David J Voce; Thomas E Darga; Ralph R Weichselbaum; Bakhtiar Yamini
Journal:  Mol Cell       Date:  2011-12-09       Impact factor: 17.970

3.  Retroviral transduction of a mutant methylguanine DNA methyltransferase gene into human CD34 cells confers resistance to O6-benzylguanine plus 1,3-bis(2-chloroethyl)-1-nitrosourea.

Authors:  J S Reese; O N Koç; K M Lee; L Liu; J A Allay; W P Phillips; S L Gerson
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-26       Impact factor: 11.205

4.  Substrate spectrum of human excinuclease: repair of abasic sites, methylated bases, mismatches, and bulky adducts.

Authors:  J C Huang; D S Hsu; A Kazantsev; A Sancar
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-06       Impact factor: 11.205

5.  O6-methylguanine-induced cell death involves exonuclease 1 as well as DNA mismatch recognition in vivo.

Authors:  Joanna Klapacz; Lisiane B Meira; David G Luchetti; Jennifer A Calvo; Roderick T Bronson; Winfried Edelmann; Leona D Samson
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-05       Impact factor: 11.205

6.  Aldehyde dehydrogenase 1A1--a new mediator of resistance to temozolomide in glioblastoma.

Authors:  Andrea Schäfer; Julian Teufel; Florian Ringel; Marcus Bettstetter; Ingrid Hoepner; Michael Rasper; Jens Gempt; Julia Koeritzer; Friederike Schmidt-Graf; Bernhard Meyer; Christoph P Beier; Jürgen Schlegel
Journal:  Neuro Oncol       Date:  2012-11-06       Impact factor: 12.300

7.  Translesion Synthesis of 2'-Deoxyguanosine Lesions by Eukaryotic DNA Polymerases.

Authors:  Ashis K Basu; Paritosh Pande; Arindam Bose
Journal:  Chem Res Toxicol       Date:  2016-11-01       Impact factor: 3.739

8.  Potentiation of temozolomide and BCNU cytotoxicity by O(6)-benzylguanine: a comparative study in vitro.

Authors:  S R Wedge; J K Porteus; B L May; E S Newlands
Journal:  Br J Cancer       Date:  1996-02       Impact factor: 7.640

9.  3-aminobenzamide and/or O6-benzylguanine evaluated as an adjuvant to temozolomide or BCNU treatment in cell lines of variable mismatch repair status and O6-alkylguanine-DNA alkyltransferase activity.

Authors:  S R Wedge; J K Porteous; E S Newlands
Journal:  Br J Cancer       Date:  1996-10       Impact factor: 7.640

10.  Tunable Stability of Imidazotetrazines Leads to a Potent Compound for Glioblastoma.

Authors:  Riley L Svec; Lucia Furiassi; Christine G Skibinski; Timothy M Fan; Gregory J Riggins; Paul J Hergenrother
Journal:  ACS Chem Biol       Date:  2018-11-08       Impact factor: 5.100

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.